Nu Skin Q2 Revenue Plunges 17%, GAAP EPS Swings to $(5.14) on Impairment; Guides FY26 Adj. EPS $0.70-$0.90
NUS is trading near its 52-week low of $4.89 (8.5% below the low).
Summary
Nu Skin reported Q2 revenue of $320.1M, down 17% YoY, with GAAP EPS of $(5.14) due to large non-cash charges. Adjusted EPS was $0.20. Full-year adjusted EPS guidance was set at $0.70-$0.90.
Key Events · Earnings and Guidance · NUS
-
Revenue Miss and Broad Decline
Q2 revenue fell 17% to $320.1M, missing the lone analyst estimate by $25M. All segments declined, with Nu Skin down 15.5% and Rhyz down 25%.
-
GAAP Loss Driven by Non-Cash Charges
GAAP EPS swung to $(5.14) from $0.43 a year ago, primarily due to a $78.9M impairment charge and a $167.5M valuation allowance on deferred tax assets. Adjusted EPS was $0.20.
-
Deteriorating Operating Metrics
Customers declined 14% to 660,037, Paid Affiliates fell 8% to 120,291, and Sales Leaders dropped 9% to 26,998, indicating weakening sales force and demand.
-
Full-Year Guidance Implies Continued Pressure
2026 revenue guidance of $1.28B-$1.35B represents a 9%-14% decline. Adjusted EPS guidance of $0.70-$0.90 compares to $0.65 in the first half of 2025, suggesting ongoing headwinds.
Analysis · NUS · Trade & Services
A sharp 17% revenue decline to $320.1 million defined Nu Skin's second quarter, missing the lone analyst estimate by $25 million. GAAP earnings swung to a loss of $5.14 per share, driven by a $78.9 million non-cash impairment charge and a $167.5 million valuation allowance against deferred tax assets. Excluding these items, adjusted EPS was $0.20, near the midpoint of guidance. The company's core metrics deteriorated across the board: customers fell 14%, paid affiliates dropped 8%, and sales leaders declined 9%. Management issued full-year 2026 adjusted EPS guidance of $0.70 to $0.90 on revenue of $1.28 billion to $1.35 billion, implying continued pressure. The stock trades near its 52-week low, and the results reinforce the challenging operating environment.
At the time of this filing, NUS was trading at $4.48 on NYSE in the Trade & Services sector, with a market capitalization of approximately $250M. The 52-week trading range was $4.89 to $14.62. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.